Preclinical evaluation of 'whole' cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes

Ali, SA, Mclean, CS, Boursnell, MEG, Martin, G, Holmes, CL, Reeder, S, Entwisle, C, Blakeley, DM, Shields, JG, Todryk, S, Vile, R, Robins, RA and Rees, RC ORCID: https://orcid.org/0000-0002-4574-4746, 2000. Preclinical evaluation of 'whole' cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes. Cancer Research, 60 (6), pp. 1663-1670. ISSN 0008-5472

Full text not available from this repository.

Item Type:	Journal article
Publication Title:	Cancer Research
Creators:	Ali, S.A., Mclean, C.S., Boursnell, M.E.G., Martin, G., Holmes, C.L., Reeder, S., Entwisle, C., Blakeley, D.M., Shields, J.G., Todryk, S., Vile, R., Robins, R.A. and Rees, R.C.
Date:	2000
Volume:	60
Number:	6
ISSN:	0008-5472
Divisions:	Schools > School of Science and Technology
Record created by:	EPrints Services
Date Added:	09 Oct 2015 09:53
Last Modified:	25 Nov 2021 09:45
URI:	https://irep.ntu.ac.uk/id/eprint/4264

Actions (login required)

Edit View

Statistics

Views

Downloads